跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PULMORIS ambrisentan 5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PULMORIS ambrisentan 5 mg tablet blister pack
Approved
STANDARD
PULMORIS ambrisentan 5 mg tablet blister pack
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
00536697c58e5f0f
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
00536697c58e5f0f
Product Name
PULMORIS ambrisentan 5 mg tablet blister pack
Artg Id
282338
Artg Name
PULMORIS ambrisentan 5 mg tablet blister pack
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2017-09-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/73f07cf4843042d850bcf6426fb2bd45.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f437100388d79dc6da071452967c1810.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
00536697c58e5f0f
Type
Standard
Back to TGA Approvals